Arcus Biosciences (RCUS) Operating Income (2017 - 2025)
Historic Operating Income for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to -$142.0 million.
- Arcus Biosciences' Operating Income fell 3523.81% to -$142.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$375.0 million, marking a year-over-year decrease of 1792.45%. This contributed to the annual value of -$330.0 million for FY2024, which is 294.12% up from last year.
- Arcus Biosciences' Operating Income amounted to -$142.0 million in Q3 2025, which was down 3523.81% from -$8.0 million recorded in Q2 2025.
- Over the past 5 years, Arcus Biosciences' Operating Income peaked at $281.0 million during Q4 2021, and registered a low of -$142.0 million during Q3 2025.
- Over the past 5 years, Arcus Biosciences' median Operating Income value was -$78.1 million (recorded in 2021), while the average stood at -$61.5 million.
- The largest annual percentage gain for Arcus Biosciences' Operating Income in the last 5 years was 64274.87% (2021), contrasted with its biggest fall of 513453.61% (2021).
- Over the past 5 years, Arcus Biosciences' Operating Income (Quarter) stood at $281.0 million in 2021, then plummeted by 126.33% to -$74.0 million in 2022, then fell by 22.97% to -$91.0 million in 2023, then dropped by 13.19% to -$103.0 million in 2024, then plummeted by 37.86% to -$142.0 million in 2025.
- Its Operating Income was -$142.0 million in Q3 2025, compared to -$8.0 million in Q2 2025 and -$122.0 million in Q1 2025.